{
    "organizations": [],
    "uuid": "5866c6ea14a523790f7d76deb35e443ea612ac52",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-3sbio-announces-tpiao-injection-ge/brief-3sbio-announces-tpiao-injection-gets-approval-for-clinical-trials-for-additional-indication-by-cfda-idUSFWN1QC0YW",
    "ord_in_thread": 0,
    "title": "BRIEF-3SBio Announces Tpiao Injection gets Approval For Clinical Trials For Additional Indication By CFDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - 3SBio Inc:\n* TPIAO INJECTION GRANTED APPROVAL FOR CLINICAL TRIALS FOR ADDITIONAL INDICATION BY CHINA FOOD AND DRUG ADMINISTRATIONâ€‹ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T22:13:00.000+02:00",
    "crawled": "2018-02-23T15:45:34.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "3sbio",
        "inc",
        "tpiao",
        "injection",
        "granted",
        "approval",
        "clinical",
        "trial",
        "additional",
        "indication",
        "china",
        "food",
        "drug",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}